1. [Picotamide: use in chronic obliterative arteriopathies of the lower limbs].
- Author
-
Tazza G, Tazza R, Valentini M, Leoni G, Avenia N, and Ragusa M
- Subjects
- Aged, Arterial Occlusive Diseases diagnosis, Female, Humans, Male, Middle Aged, Phthalic Acids administration & dosage, Time Factors, Arterial Occlusive Diseases drug therapy, Leg blood supply, Phthalic Acids therapeutic use
- Abstract
In the present study the authors evaluated treatment efficiency and patient compliance of medium-term therapy with Picotamide, given in doses of 900 mg/die for the first 15 days, and 600 mg/die up to the completion of a three-month period, to 50 patients affected by vaso-occlusive arterial disease of the lower limbs. At follow-up visits the following controls have been carried out: CW Doppler sonography of the lower limbs, Maximum Walking Distance (M.W.D.), Red blood cell count, White blood cell count, Platelet count, Haemoglobin and Fibrinogen levels. At the end of the three-month therapy period the Ankle-Arm parameters remained unchanged.
- Published
- 1991